Identification and structure–activity relationship exploration of uracil-based benzoic acid and ester derivatives as novel dipeptidyl Peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus-Reference-Cited by-同舟云学术

Identification and structure–activity relationship exploration of uracil-based benzoic acid and ester derivatives as novel dipeptidyl Peptidase-4 inhibitors for the treatment of type 2 diabetes mellitus

Published:2021-12 Issue: Volume:225 Page:113765
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Li Qing,Deng Xiaoyan,Jiang Neng,Meng Liuwei,Xing Junhao,Jiang Weizhe,Xu Yanjun

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference29 articles.

1. IDF Diabetes Atlas, 9th edn. Brussels, Belgium;International Diabetes Federation,2019

2. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021;American Diabetes Association;Diabetes Care,2021

3. Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas, 9th edition;Williams;Diabetes Res. Clin. Pract.,2020

4. Glucose lowering treatment modalities of type 2 diabetes mellitus;Gokcay Canpolat;Adv. Exp. Med. Biol.,2021

5. Therapeutic medications against diabetes: what we have and what we expect;Hu;Adv. Drug Deliv. Rev.,2019

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of the selective and nanomolar inhibitor of DPP-4 more potent than sitagliptin by structure-guided rational design;European Journal of Medicinal Chemistry;2024-12

2. Computational approaches for lead compound discovery in dipeptidyl peptidase-4 inhibition using machine learning and molecular dynamics techniques;Computational Biology and Chemistry;2024-10

3. Recent advances and structure-activity relationship studies of DPP-4 inhibitors as anti-diabetic agents;Bioorganic Chemistry;2024-05

4. Structural Insight on GPR119 Agonist as Potential Therapy for Type II Diabetes: A Comprehensive Review;Mini-Reviews in Medicinal Chemistry;2023-11

5. Development of Long-Acting Dipeptidyl Peptidase-4 Inhibitors: Structural Evolution and Long-Acting Determinants;Journal of Medicinal Chemistry;2023-08-30